Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities
Hämostaseologie · 01.06.2023 · 43 (03) · 208-214
DOI: 10.1055/a-1972-8983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.06.2023. Verfasst von Anna C Strauss und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Hemophilia A, Osteoporosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Patients with hemophilia (PWHs) suffer from an increased risk of osteoporosis. Multiple hemophilia and hemophilic arthropathy associated factors correlate with a low bone mineral density (BMD) in PWHs. The aim of this study was to assess the long-term development of BMD in PWH as well as to analyze potentially influencing factors.
Methods
A total of 33 adult PWHs were evaluated in a retrospective study. General medical history, specific-hemophilia-associated comorbidities, joint status using the Gilbert score, calcium level, and vitamin D level as well as at least two results of bone density measurements with a minimum range of 10 years per patient were taken into account.
Results
The BMD did not change significantly from one point of measurement to the other. A total of 7 (21.2%) cases of osteoporosis and 16 (48.5%) cases of osteopenia were identified. The two following significant correlations could be revealed: the higher the patients' body mass index, the higher their BMD (r = 0.41; p = 0.022). Moreover, a high Gilbert score came along with a low BMD (r = −0.546; p = 0.003).
Conclusion
Even if PWHs frequently suffer from a reduced BMD, our data suggest that their BMD remains constant on a low level in the course of time. A risk factor of osteoporosis often found in PWHs is a vitamin D deficiency and joint destruction. Therefore, a standardized screening of PWHs on BMD reduction by collecting vitamin D blood level and assessing joint status seems appropriate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
- Department of Orthopaedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.
- Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Zitieren
APA
Strauss, A. C., Muellejans, P., Koob, S., Goldmann, G., Pennekamp, P. H., Wallny, T. A., Oldenburg, J., & Strauss, A. C. (2023). Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities. Hämostaseologie, 43(03), 208-214. https://doi.org/10.1055/a-1972-8983
Vancouver
Strauss AC, Muellejans P, Koob S, Goldmann G, Pennekamp PH, Wallny TA, et al. Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities. Hämostaseologie. 2023;43(03):208-214. doi:10.1055/a-1972-8983
BibTeX
@article{Strauss2023,
author = {Strauss, Anna C and Muellejans, Pius and Koob, Sebastian and Goldmann, Georg and Pennekamp, Peter H and Wallny, Thomas A and Oldenburg, Johannes and Strauss, Andreas C},
title = {Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities},
journal = {Hämostaseologie},
year = {2023},
volume = {43},
number = {03},
pages = {208--214},
doi = {10.1055/a-1972-8983}
}
EUVIMED